Navigation Links
Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
Date:5/14/2008

NICE, France, May 14 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII) reported for the first time at the European Stroke Conference detailed analyses supporting the dosing regimen in NTI's two ongoing Phase 3 studies of Viprinex(TM) (ancrod) for ischemic stroke. The company also provided information as to why it believes these studies are more likely to be successful in treating ischemic stroke than previous Phase 3 clinical trials conducted by others using the same snake venom-derived agent.

David E. Levy, M.D., Vice President, Clinical Development at NTI, presented his retrospective analysis of data from the prior North American and European Phase 3 stroke trials of Viprinex involving more than 1,700 patients. Viprinex has been shown to rapidly reduce blood levels of fibrinogen, an important agent involved in blood clotting and blood viscosity. Elevated fibrinogen levels are a risk factor for stroke and may be associated with greater stroke disability. Prior studies with Viprinex that target fibrinogen have shown a benefit from this approach.

"The prior studies of Viprinex showed improved efficacy, but used a dosing regimen that infused the drug over five to seven days, which kept fibrinogen levels low for too long, compromising safety," said Dr. Levy, the key presenter. "NTI has changed the treatment paradigm to a single, three-hour intravenous dose designed to reduce fibrinogen levels quickly, while avoiding the prolonged low fibrinogen levels that were tried previously. Stopping the infusion after three hours permits fibrinogen to return to normal levels much faster than when the drug is given over five to seven days."

Dosing in the successful North American Phase 3 trial was c
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
2. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
3. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
4. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
5. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
6. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Napo Presents at ISPOR Meeting in Toronto
9. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
10. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
11. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  CAS Medical Systems, Inc. (NASDAQ: CASM ) ... today announced that Thomas M. Patton , ... nd Annual Marcum MicroCap Conference on Thursday, May 30, ... York City . The presentation is scheduled ... room and will be available via a live webcast at ...
(Date:5/23/2013)... May 23, 2013 Halozyme Therapeutics, Inc. ... appointment of David A. Ramsay ... most recently Vice President, Corporate Development at Halozyme. ... "With his established financial management experience and ... working in our commercial group for the last ...
(Date:5/23/2013)... May 23, 2013 EarlySense, the ... that the prize for ,Best Novel Idea, at the ... Emergency Teams International Conference, hosted this year in the ... to a clinical research team studying the impact of ... in Los Angeles . The prize ...
Breaking Medicine Technology:CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4
... Radiation Therapy Services Holdings, Inc. ("Radiation Therapy Services" or the ... the Wells Fargo Securities 2011 Healthcare Conference on Wednesday, June ... being held at the Intercontinental Hotel in Boston, MA. ... be available by visiting the Events section of the Company,s ...
... N.J., June 17, 2011 Affineti Biologics has received ... Capital Group (FVCG) to advance its research in the ... discoveries in oral biology and dental medicine. ... company invested in Affineti because positive results from studies ...
Cached Medicine Technology:Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products 2
(Date:5/23/2013)... ROCHESTER, Minn. -- Mayo Clinic researchers have used next ... more aggressive prostate cancer tumors have similar genetic origins, ... appear online today in the journal Cancer Research ... DNA alterations using next generation sequencing in adjacent Gleason ... genomics with changes in pathology," says ,John Cheville, M.D., ...
(Date:5/23/2013)... 2013 Transvaginal mesh lawsuit ... to move forward in a federal multidistrict litigation underway ... Bernstein Liebhard LLP reports. In an Order issued ... C.R. Bard to seal emails that included supplier information ... confidential, proprietary information about its suppliers. The emails were ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 The vast ... great deal of control over their level of physical ... yet far fewer are actually taking that control. ... Information Council (IFIC) Foundation’s 2013 Food & Health Survey. ... say it’s possible to have “a great deal of ...
(Date:5/23/2013)... On April 29th, 2013, UV Technologies issued ... H7N9 cases and deaths. The headline read, " UV Technologies, ... in Northern Hemisphere as Available Daylight Increases .” In fact, ... , Quoting Kevin McGuire, president of UV Technologies, "The ... in the spring and leaves changing in the fall. The ...
(Date:5/23/2013)... Cheap Concert Tickets announces that Paul McCartney ... stadiums throughout North America. This well known ticket website ... tickets to help McCartney fans see Sir Paul live in ... that she is also offering the customer appreciation code SAVE ... baby boomer, she is also a huge McCartney fan and ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 2Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 3Health News:Americans Experience “Control Gap” Regarding Their Weight, Diet, Activity Level; Rate Their Overall Diet a “B-Minus” 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2
... ... more insecure about how they look, often creating depression. Jami Lin presents how not ... body appreciation. , ... (Vocus) August 24, 2009 -- From Hollywood glam to commercials promising ageless beauty, women ...
... ... and forthright look at why Americans are overweight, overwhelmed, and confused, and what ... ... August 25, 2009 -- The question is not whether Americans are getting fatter ...
... of melanosomes--the organelles in pigment-producing cells--may enhance the activity ... new study published online August 24 in the ... examine the role of melanosomes in the sensitivity of ... Hearing, Ph.D., Michael M. Gottesman, M.D., of the Laboratory ...
... , SCOTTSDALE, Ariz., Aug. 24 Matrixx ... will host its 2009 Annual Meeting of Stockholders at 10:00 a.m. ... Scottsdale, Arizona. The purpose of the meeting is to elect three ... two-year or three-year term, or until their successors are elected; to ...
... , , , ... health care, says Legion , , LOUISVILLE, ... expansion of the healthcare systems administered by the Department of Veterans Affairs ... In resolutions adopted by members of its National Executive Committee (NEC), the ...
... those who did it a lot fared worse on tests ... You may think e-mailing, texting, talking on the phone and ... efficient, but new research suggests the opposite is true. , ... is a challenge for the human brain, according to a ...
Cached Medicine News:Health News:Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL 2Health News:Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL 3Health News:Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL 4Health News:The Naked Truth: Overweight, Overwhelmed and Confused 2Health News:Matrixx Initiatives to Webcast 2009 Annual Stockholder Meeting Wednesday, August 26, 2009 2Health News:The American Legion Calls for Revamping and Expansion of Veterans and Military Health Care 2Health News:Chronic Media Multi-Tasking Makes It Harder to Focus 2Health News:Chronic Media Multi-Tasking Makes It Harder to Focus 3
... provides a simple, fast and cost-effective method ... samples. This system utilizes guanidine thiocyanate and ... and denature proteins. Purified viral RNA is ... and RNase protection assays. This system is ...
... The Titertek MAP-C2 is designed for ... the instrument is the S60 Stacker that ... removable magazines. The MAP-C2 base model is ... assembly. Auxiliary Digiflex pipetting units may be ...
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
The IL 682 is the Gold Standard for CO-Oximetry analysis....
Medicine Products: